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Abstract
Lipopolysaccharides or endotoxins are components of Gram-negative enterobacteria that cause septic shock in mammals.
However, a LPS carrying hexa-acyl lipid A moieties is highly endotoxic compared to a tetra-acyl LPS and the latter has been
considered as an antagonist of hexa-acyl LPS-mediated TLR4 signaling. We investigated the relationship between the
structure and the function of bacterial LPS in the context of human and mouse dendritic cell activation. Strikingly, LPS with
acylation defects were capable of triggering a strong and early TLR4-dependent DC activation, which in turn led to the
activation of the proteasome machinery dampening the pro-inflammatory cytokine secretion. Upon activation with tetra-
acyl LPS both mouse and human dendritic cells triggered CD4+ T and CD8+ T cell responses and, importantly, human
myeloid dendritic cells favored the induction of regulatory T cells. Altogether, our data suggest that LPS acylation controlled
by pathogenic bacteria might be an important strategy to subvert adaptive immunity.
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Introduction
Dendritic cells (DC) play a key role in initiating and controlling
the magnitude and the quality of adaptive immune responses
[1,2]. Upon exposure to microbial stimuli, DC undergo a matu-
ration process characterized by an increased formation of MHC–
peptide complexes, the up-regulation of co-stimulatory molecules,
chemokine receptors and cytokine production [1,2,3]. Cytokines
produced by DC play a key role in determining the type of
generated CD4+ helper T cell (TH) responses leading to TH1, TH2
or TH17 responses [1,2]. Moreover, DC play a pivotal role in the
control of central tolerance and the induction of immune tolerance
in the periphery. The ability of DC to induce tolerance depends on
several parameters such as their maturation stage, anti-inflamma-
tory and immunosuppressive agents, the nature of microbial
stimuli, and the tissue microenvironment. In addition to deleting T
cells, tolerogenic DC induce the differentiation and proliferation of
T cells with regulatory/suppressive functions known as regulatory
T cells (Treg) [4].
Lipopolysaccharide (LPS) is an important virulence factor of
Gram-negative bacteria responsible for septic shock in mammals.
LPS is the major molecule of the bacterial outer membrane and
can be massively released into the host during the course of
infection [5,6]. LPS consists of the O-polysaccharide chain, the
oligosaccharide core region and the lipid A. Typical LPS such as
those of E. coli and most enteric bacteria express a lipid A
composed of a bisphosphorylated glucosamine disaccharide
carrying two amide- and two ester-linked acyl and hydroxyacyl
chains. Additional acyloxyacyl chains are commonly present,
resulting in penta or hexa-acyl lipid A, the dominant molecular
lipid A species in most wild type enterobacteria [7,8]. It has been
shown that variations of structural arrangements of lipid A such as
a reduction in the number of charges or the number of acyl chains
or a change in their distribution or saturation degree result in
a dramatic reduction in endotoxicity. For instance, the synthetic
precursor tetracyl lipid IVa has been described as a non-endotoxic
molecule and proposed as an antagonist of hexa-acyl endotoxic
LPS [9,10]. Moreover, some pathogens like the yersiniae modulate
the degree of acylation of the lipid A depending upon the
environmental conditions. Most notably, growth at 37uC causes
Yersinia pestis to synthesize tri- and dominant tetra-acyl lipid A, with
no hexa-acyl and only small amounts of penta-acyl molecules.
Since these bacteria move from 20–25uC to 37uC when trans-
mitted from the flea to the mammal host, Y. pestis express tetra-acyl
lipid A which displays low immunostimulatory properties in
mammals. This change has been described as a mark of pathogen
adaptation to the host environment [7].
In this study, we investigated the relationship between lipid A
acylation and the immunostimulatory properties of LPS in the
context of mouse and human DC activation. We show that LPS
with acylation defects described as not endotoxic are capable of
inducing a strong and early TLR4-dependent cell activation. This
leads to the activation of the proteasome machinery and the
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degradation of newly synthetized pro-inflammatory cytokines.
Mouse and human DC activated by tetra-acyl LPS trigger CD4+
and CD8+ T cell responses. Moreover, human DC activated by
LPS with acylation defects display a semi-mature phenotype and
induce high levels of regulatory T cells (Treg).
Materials and Methods
Ethics Statement
Animal experimentation was conducted in strict accordance
with good animal practice as defined by the French animal welfare
bodies (Law 87–848 dated 19 October 1987 modified by Decree
2001–464 and Decree 2001–131 relative to European Conven-
tion, EEC Directive 86/609). All animal work was approved by
the Direction De´partmentale des Services Ve´te´rinaires des
Bouches du Rhoˆne (authorization number 13.118). INSERM
guidelines have been followed regarding animal experimentation
(authorization No. 02875 for mouse experimentation).
Blood from healthy adult donors were collected at the Baylor
Hospital Liver Transplant Clinic (Dallas, TX) after obtaining
written informed consent. This study, including the consent form,
was approved by the Institutional Review Board (IRB) of the
Baylor Research Institute (BRI) (Dallas, TX). Any medical issue
during blood collection from healthy donors was written and
reported to the IRB at BRI.
Lipopolysaccharides
The methods used in the extraction, purification and charac-
terization of the LPS used in this study have been described
previously (Lapaque et al, 2006). Briefly, Y. pestis KIM6, E. coli
MLK3 and its lipid A mutants MLK53 htrB2 (lauroyl-transferase),
MLK 1067 msbB2 (miristoyl-transferase) and MLK
986 htrB2/msbB2 were grown at the appropriate temperature,
crude LPS obtained by the phenol-water method and then
purified to remove traces of contaminant lipids and lipoproteins.
The degree of lipid A acylation was determined by nano-
electrospray ionization time-of-flight mass spectrometry (ESI-
TOF-MS) (Lapaque et al, 2006). For all experiments, LPS variants
have been used at the concentration of 100 ng/ml. Lipid Iva was
purchased from PeptaNova.
Antibodies and Reagents
The primary antibodies used for immunofluorecence micros-
copy were: mouse FK2 antibody (anti-mono- and polyubiquitiny-
lated conjugates) (Enzo Life Science), affinity purified rabbit
‘‘Rivoli’’ antibody against murine I-A, NF-kB subunit p65/ReiA
(Santa Cruz), CD11c (Bolegend). Pam2CSK4 was purchased from
InvivoGen to activate DC. Antibodies used for flow cytometry
included APC-CD11c (1 in 100), FITC-CD40 (1 in 50), FITC-
CD80 (1 in 50), PE-CD86 (1 in 400), PE-IA-IE (MHC class II)
(Pharmingen) (1 in 800), as well as PB-CD8 (1 in 200), A700-
CD45.2 (1 in 300), APC-CD44 (1 in 400), PE-Cy7-CD25 (1 in
1500), APC-CD62L (1 in 400) (BD Biosciences and eBiosciences).
For intracellular labeling of cytokines, IL-12 (p40/p70)-PE and
TNF-a PE monoclonal antibodies (1 in 100)(Pharmingen) were
used. The Aqua Dead Cell Stain (Invitrogen) was used to eliminate
dead cells. Ovalbumine (OVA) was purchased from EndoGrade
with purity.98% and endotoxin concentration ,1EU/mg.
SIINFEKL peptide was purchased from Schafer-N. Human
mDC were sorted from PBMC of blood from healthy donors
using lineage cocktail-FITC (BD Biosciences), CD123-PE (BD
Biosciences), CD11c-APC (Biolegend), HLA-DR-Quantum Red
(Sigma). Human mDC were stained with CD86-PE, CD83-FITC,
CD40-APC and HLA-DR-PB (eBiosciences or Biolegends). 7-
AAD was used to exclude dead cells. For intracellular labelling
IL13-APC, INF-c-PE-Cy7, IL-17-PE and Granzyme B-APC
antibodies were used. Isotype matched controls were used
appropriately. Alexa Fluor 647 conjugated phospho-specific
antibodies were used for Phospho flow experiments on human
IL-4 DC and were all from BD Biosciences. Akt(S478), Btk(Y557)/
Itk(Y511), CREB(S133)/ATF1(S63), ERK1/2(T202/Y204), IRF-
7(S477/S479), Lck(Y505), NF-kB p65(S529), PLC-c1 (Y783),
PLC-c2 (Y759), p38 MAPK(T180/Y182), b-Catenin (S45), SHP-
2(Y542), Src(Y418), SLP-76(Y128), S6(S235/S236),
STAT1(Y701), STAT1(S727), STAT3(Y705), STAT3(S727),
STAT4(S693), STAT5(S694), STAT6(Y641), 4EBP1(T36/T45),
Zap70(Y319)/Syk(Y352), JNK(T183/Y185).
Mice and Cells
C57Bl/6 mice from Jackson Laboratory and OT-I, OT II TCR
transgenic mice on C57Bl/6 background were used. C57BL/6,
Tlr42/2 and Tlr22/2 mice were maintained at the CIML animal
house, France. Mouse bone marrow-derived DC (BMDC) and
macrophages (BMDM) were prepared from 7–8 week-old female
C57BL/6 mice as previously described (Lapaque et al, 2006).
Human DC
Human IL-4 monocyte-derived DC were generated from Ficoll-
separated PBMC from healthy volunteers. Monocytes were
enriched from the leukopheresis according to cellular density
and size by elutriation as per manufacturer’s recommendations.
For DC generation, monocytes were resuspended in serum-free
Cellgro DC culture supplemented with GM-CSF and IL-4. Blood
myeloid DC (HLA-DR+CD11c+CD1232Lin2) were sorted from
fresh PBMC using FACSAria (BD Biosciences). Naı¨ve CD4+ and
CD8+ T cells (CD45RA+CD45RO2) (purity.99.2%) were
purified by FACS-sorting.
Immunofluorescence Microscopy
For immunofluorescence microscopy, 26105 stimulated
BMDCs on coverslips were fixed in 3% paraformaldehyde at
RT for 15 min, washed twice in PBS 1X and processed for
immunofluorescence labelling. To stain NF-kB, mouse BMDCs
and BMDMs were permeabilized with PBS 1X 1% saponin (for
10 min at RT) and then saturated with PBS 1X 2% BSA (for 1 h
at RT). CD11c (1 in 100), NF-kB subunit p65/ReiA (1 in 250) and
MHC II (1 in 300) were used as primary antibodies. After staining,
samples were examined on a Zeiss LSM 510 laser scanning
confocal microscope for image acquisition. Images were then
assembled using Adobe Photoshop 7.0. Quantifications were done
by counting at least 300 cells in 3 independent experiments.
Flow Cytometry
To analyse mouse BMDC maturation, 26105 cells were
stimulated and stained with antibodies for classical activation
markers. Appropriate isotype antibodies were used as controls.
After staining, cells were washed with PBS 2% FCS, then PBS 1X
and fixed in 1.5% paraformaldehyde before analysis on a FACS-
calibur cytometer (Becton Dickinson). Cells were always gated on
CD11c for analysis and 100,000 CD11c+ events were collected
from each sample. For the intracellular staining of IL-12 and
TNF-a in mouse BMDCs, BD Cytofix/Cytoperm and BD Perm/
Wash buffers were used. At least 100.000 events were collected on
FACSCanto II (BDBiosciences). For mouse CD4 and CD8 T cell
assays, viable cells were analyzed for the decrease of CFSE
(proliferation) and the expression of CD25, CD44 and CD62L
(diluted in PBS 1X EDTA 2 mM). Human mDC or IL4-DC
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activation was analyzed by checking the surface expression of
maturation markers CD40, CD83, CD86, HLA-DR after 16 h or
72 h of cell treatment with LPS variants, respectively. Flow
cytometry analysis was performed using the FlowJo software.
Histograms were drawn from and median fluorescence intensity
values were determined on gated populations. At least 100,000
events were collected on FACSCanto II (BDBiosciences) or
FACSAria (BDBiosciences).
Cytokine Measurement
Murine IL-12 and TNF-a were quantified in culture super-
natants of stimulated DC by sandwich enzyme-linked immuno-
sorbent assays (ELISA) according to the manufacturer’s protocol
(Abcys). Human cytokine (IL-6, TNF-a, and IL-12p40) were
determined using the BeadLyte cytokine assay kit (Upstate, MA).
Immunoblotting
30 mg of cell lysates were subjected to SDS-PAGE PAGE and,
after transfer to nitrocellulose, the membrane was probed with
a polyclonal antibody against phospho-S6 or S6 (Cell Signaling
Technology) or an anti-actin antibody. Blots were subjected to
enhanced chemiluminescence detection (ECL, PIERCE).
Quantitative RT-PCR
Total RNA was isolated with Trisol reagent, was reverse
transcribed and analyzed by real-time quantitative PCR using the
Power SYBR Green PCR Master Mix (Applied Biosystems). All
reactions were performed in triplets. Data were acquired on a 7500
Fast Real-Time PCR system (Applied Biosystems) and were
normalized to the expression of actin mRNA transcripts in
individual samples. For a given real-time qRT-PCR sample, the
RNA expression level was calculated from cycle threshold (Ct). In
our analysis, given gene expression is shown as mean normalized
expression (MNE) relative to the expression of b-actin. The
following primers were used for qPCR amplification:RT b-actin
(sense): GACGGCCAGGTCATCACTATTG, RT b-actin (anti-
sense): CAAGAAGGAAGGCTGGAAAAGA, p35 sense :
59ctcctgtgggagaagcagac39, p35 anti-sense: 59acagggtgatgggc-
tatctga39, p40 sense:59CACACTGGACCAAAGGGACT39p40
anti-sensereverse: 59ATTATTCTGCTGCCGTGCT39, TNF-
a sense: 59CATCTTCTCAAAATTCGAGTGACAA39TNF-a,
anti-sense : 59TGGGAGTAGACAAGGTACAACCC39. 3 in-
dependent experiments were done and one representative is
shown.
In vitro Antigen Presentation Assays
BMDC (3000 cells) were incubated overnight in 96-well culture
plates either with media or OVA. T cells obtained from the lymph
nodes and the spleen of OT-I and OT-II Rag-22/2 mice were
purified with the T cell enrichment kit from Dynal following
manufacturer’s instructions. For CD4 and CD8 T cell pro-
liferation assays, purified T cells were labeled with 10 mM
carboxyfluorescein diacetate succinimidyl ester (CFSE from
Invitrogen) for 10 min at 37uC. OT-II and OT-I cells (20000
cells) were added to BMDC that had been stimulated for 8 h with
different LPS and then washed. The proliferation of OT-I and
OT-II T cells was assessed after 3 days of co-culture by flow
cytometry. The cells were washed and stained with anti-CD4 and
anti-CD8 antibodies for identification. For CD4 and CD8 T cell
activation assays, purified T cells were co-cultured with BMDC
previously stimulated for 8 h with different LPS. After 3 days, the
expression of surface markers such as CD25, CD44 and CD62L
was analyzed by flow cytometry to study the cellular activation
level.
Co-culture of OT-II T cells with BMDC
CD4+ T cells were isolated from the spleen of OT-II Rag-22/2
mice using a CD4+ T cell isolation kit (Dynal; Invitrogen). Purity
was determined by staining with CD4, CD5, and TCR Va2. A
total of 36103 BMDC stimulated for 8 h with different LPS were
co-cultured with 26104 OT-II Rag-22/2 T cells in the presence
of ovalbumin, ovalbumin (257–264) peptide (0.06 mg/mL) and of
TGF-b (1 ng/mL) as indicated. After 5 days of culture, the
expression of Foxp3 and CD25 was evaluated.
Human CD4+ and CD8+ T cell Responses
56103 blood mDC were co-cultured with CFSE-labeled
allogeneic naı¨ve CD4+ T and CD8+ T cells (1–26105). The
DC/T ratio was 1:1000 and 1:20, respectively. Cell proliferation
was tested by measuring CFSE-dilution on day 6. On day 7, the
production of intracellular cytokines (INF-c, IL-17, IL-13) and
Granzyme B were analyzed after 6 h of T cell stimulation by PMA
and Ionomycine, in the presence of Brefeldin A. Cells were stained
for analysis by flow cytometry using different fluorochrome-
conjugated antibodies.
Phospho-flow Analysis with Fluorescent Cell Barcoding
(FCB)
Monocyte-derived IL4 DC were generated as previously
described. Briefly, human monocyte were enriched with human
monocyte enrichment kit without CD16 depletion (Stemcell
Technologies, Canada) and suspended in CellGro DC medium
(CellGenix, Germany) with GM-CSF and IL-4. On day 6, cells
were washed and resuspended at 1 million/mL in RPMI
supplemented with 2 mM L-Glutamine, 1 mM Sodium pyruvate,
1X non essential amino acid, 50 mM b-ME, and 10 mM HEPES
+10% FBS, and then cultured for 2 h in a CO2 incubator. Cells
were stimulated with different LPS (100 ng/ml) for 2, 5, 10, 30,
60, and 180 min. Equal amount of medium was used for
stimulation control. All samples were immediately fixed by adding
PFA (final 1.6%) for 10 min at RT. Fixed cells were centrifuged
and washed once with PBS, and then permeabilized with ice-cold
Methanol (500 ml/1 million cells) for 10 min at 4uC. Two
dimension FCB was performed according to the previous report
[11]. Pacific Blue-NHS and Alexa Fluor 488-NHS (Invitrogen,
Carlsbad, CA) were added to each condition of cells at 0.02, 0.08,
0.32, 1.0, 3.0 mg/ml or 0.05, 0.2, 0.8, 3.0 mg/ml, respectively.
Each sample has a unique combination of dyes with different
concentrations. After 30 min on ice, barcoded cells were washed
three times with PBS+0.5% BSA and combined into one tube.
Combined barcorded cells were stained with Alexa Fluor 647
conjugated phospho-specific antibodies for 30 min at RT. Cells
were washed two times with PBS+0.5% BSA. For purified anti-
phospho-JNK antibody, cells were stained with secondary anti-
rabbit DyLight 649 (Jackson Immunoresearch, West Grove, PA)
for 30 min at RT and washed two times. Samples were
immediately analyzed with FACS CantoII (BD Biosciences, San
Jose, CA). Fold changes of phosphorylation were visualized as
a Heatmap. The MFI of LPS-stimulated samples were normalized
with medium-stimulated samples.
Statistical Analysis
All experiments were carried out at least 3 independent times
and all the results correspond to the means 6 standard errors.
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Statistical analysis was done using two-tailed unpaired Student’s t
test. Significance was defined when P values were ,0.05.
Results
Structural Modifications of LPS Affect Cytokine Secretion
by DC
We used an array of LPS (Table 1) differing in lipid A acylation
to study their activation properties in mouse bone marrow-derived
dendritic cells (BMDC) and bone marrow-derived macrophages
(BMDM). In addition to the classical wild type hexa-acyl LPS
purified from E. coli MLK strain, we used LPS from E. coli MLK
mutants (msbB-, htrB- and msbB2/htrB- double mutant) that
produce mostly penta-acyl and tetra-acyl lipid A (Table 1) or LPS
purified from Y. pestis KIM grown at 37uC (mainly composed of
tri- and tetra-acyl lipid A with small amounts of penta-acyl and
hexa-acyl molecules, Table 1). All LPS variants induced a BMDC
maturation characterized by an up-regulation of the surface
expression of major histocompatibility complex MHC-II and co-
stimulatory molecules (CD40, CD86) (Figure 1A). However,
significant lower levels of secreted TNF-a and IL-12 were detected
in DC stimulated by tetra-acyl LPS purified from E. coli MLK
(msbB2/htrB-) double mutants or LPS purified from Y. pestis
compared to DC stimulated with wild type E. coli hexa-acyl LPS
(Figure 1B). Moreover, the LPS variants did not induce any IFN-
a secretion (not shown). While comparing the activities of LPS
variants, we have also performed a dose-response study (not
shown). Cell treatment by 1 ng/ml of LPS triggered DC
activation, which reached a plateau at the highest concentration
(100 ng/ml). The same differences in terms of cytokine secretion
were observed when cells were treated both with 100 ng/ml and
10 ng/ml of different LPS (not shown). Similarly, in BMDM
activated by tetra-acyl LPS, TNF-a secretion was strongly
decreased compared to BMDM incubated with hexa-acyl LPS
(Figure S1) as previously observed in macrophage cell lines
[8,9,10].
We then tested the ability of tetra-acyl LPS (referred as purified
either from E. coli MLK msbB2/htrB- double mutant or Y. pestis
grown at 37uC) to induce human blood myeloid DC (mDC)
activation (Figure 1C and D). Hexa-acyl and tetra-acyl LPS
induced a similar up-regulation of classical cell surface activation
markers (HLA-DR, CD40, CD86, and CD83) (Figure 1C).
However, mDC treated with tetra-acyl LPS secreted lower levels
of IL-12, IL-6 and TNF-a than those stimulated by hexa-acyl LPS
(Figure 1D). Tetra-acyl LPS from Y. pestis, which contains small
amounts of hexa-acyl LPS had a stronger capacity to trigger IL-12,
IL-6 and TNF-a secretion (p,0.01) than LPS purified from E. coli
(msbB-, htrB-) double mutant (devoid of hexa-acyl LPS) (Figure 1D,
Table 1). Together, our data show that structural modifications of
LPS induce an intermediate phenotype of maturation in mouse
and human DC characterized by high levels of MHC-II and co-
stimulatory molecule expression, but low levels of pro-inflamma-
tory cytokine secretion.
Tetra-acyl LPS Induce a TLR4-dependent DC Activation
LPS recognition by host cells is mediated through the Toll-like
receptor 4 (TLR4/MD2/CD14) receptor complex [12]. To
determine the contribution of TLR4 in the cell activation induced
by LPS with acylation defects, BMDC derived from Tlr42/2,
Tlr22/2 and wild type mice were treated with the LPS variants.
No activation was observed in Tlr42/2 mice-derived BMDC
stimulated either by hexa-acyl or tetra-acyl LPS (p,0.001), as
measured by the secretion of TNF-a (Figure S2A). In addition,
TLR2 was not implicated in DC activation induced by the
different LPS (Figure S2B), showing that LPS preparations were
not contaminated by lipoproteins.
The measurement of DC viability following treatment with
different LPS showed that both hexa-acyl and tetra-acyl LPS
induce a very low percentage of dead cells (0.93%) (not shown).
We next tried to understand if the decrease of pro-inflammatory
cytokine secretion in BMDC activated by tetra-acyl LPS was
related to a defect in signal transduction. It has been shown that
NF-kB translocation is a key event in LPS-induced TLR4
signalling [13]. Under unstimulated conditions, NF-kB is kept in
the cytosol as an inactive form. Under hexa-acyl LPS stimulation
NF-kB is translocated into the nucleus where it can bind to
several gene promoters [13,14]. After 15 and 30 min of cell
stimulation, tetra-acyl LPS induced a significant (p,0.01)
stronger NF-kB translocation than hexa-acyl LPS (Figure 2A
and B). Similar results were observed in macrophages (Figure
S3A and B).
Since the activation of the mammalian target of rapamycin
(mTOR) pathway has been implicated in DC maturation [16], we
then analyzed the phosphorylation of the ribosomal protein S6,
one of downstream elements of the TLR4 pathway. Compared to
hexa-acyl LPS, tetra-acyl LPS induced a stronger S6 phosphor-
ylation at 30 min post-cell activation (Figure 2C). No difference for
S6 phosphorylation was observed at later time points either by
hexa-acyl or tetra-acyl LPS (Figure 2C). These data show for the
first time that LPS with acylation defects induce an early and
strong activation of the TLR4-dependent signalling pathway in
mouse DC and macrophages.
We extended this study to human monocyte-derived IL-4 DC
(Figure 3) by using the phospho-flow technology. Fluorescent cell
barcoding (FCB) was applied to analyze many conditions
simultaneously, using a collection of several anti-phosphorylated
proteins [11]. All LPS variants LPS were equally able to increase
the phosphorylation levels of several signaling molecules in-
cluding MAPKs (ERK, p38, JNK), Akt-mTOR pathway
molecules (Akt, 4EBP1, S6), and some transcription factors
(CREB, NFkB p65) (Figure 3). Interestingly, although the
patterns of phosphorylated molecules were same between LPS
variants, the kinetics and strength of the phosphorylation changes
were slightly different with several molecules (Figure 3). Y. pestis
LPS could induce phosphorylation more rapidly, while LPS
mutant caused phosphorylation more slowly and weakly than E.
coli LPS in some molecules, especially in Akt, p38 and NFkB
(Figure 3). These results suggest that as E. coli hexaacyl LPS, Y.
pestis LPS and E. coli LPS mutant could act as an agonist to
TLR4 pathway. However, structural differences in lipid A region
may modify the LPS binding capacity to the receptor, leading to
changes in activation potential. It should be also noted, E. coli
LPS mutant enhanced tyrosine phosphorylation in STAT1, 3, 5
at later time point more potently than others (Figure 3). Taken
together, LPS variants seem to activate the same signaling
pathway with different activation potential that may affect the
output and quality of immune responses induced by DC.
Thus, LPS purified from E. coli MLK (msbB-, htrB-) double
mutant and Y. pestis were able to trigger TLR4-dependent
signalling in human DC, in agreement with data obtained on
mouse BMDC (Figure 2).
Altogether these data show that LPS with acylation defects act
as agonists to the TLR4 pathway and efficiently induce signal
transduction in mouse and human DC.
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Tetra-acyl LPS Induce an Early Synthesis of Pro-
inflammatory Cytokines followed by their Proteasome-
dependent Degradation
We then investigated whether the decrease of pro-inflammatory
cytokine secretion in BMDC activated by tetra-acyl LPS was due
to a defect in cytokine synthesis (transcription/translation). BMDC
were activated with different LPS and quantitative RT-PCR used
to analyse gene expression. In BMDC treated by tetra-acyl LPS an
earlier and stronger transcription of tnf-a, p35 and p40 genes was
observed (Figure 4A) compared to BMDC treated by hexa-acyl
LPS. Therefore, the decrease of pro-inflammatory cytokine
secretion observed in Figure 4B cannot be attributed to
transcriptional defects.
We next investigated whether the defect in cytokine secretion by
DC stimulated with tetra-acyl LPS was due to a change in protein
translation (Figure 4C and D). BMDC were incubated with the
different LPS in the presence of brefeldin A to block the secretion
of newly synthesized cytokines. Intracellular levels of IL-12 and
TNF-a were analysed by flow cytometry. LPS with acylation
defects induced significant higher TNF-a and IL-12 synthesis at
2 h and 4 h post-stimulation compared to hexa-acyl LPS
(Figure 4C and D). However, at 8 h post-stimulation, the level
of intracellular cytokines was lower in DC treated with tetra-acyl
LPS than in DC treated by hexa-acyl LPS (Figure 4E). It has been
shown that glucose or energy deprivation, calcium homeostasis
perturbation or elevated synthesis of secretory proteins induce an
alteration of the Endoplasmic Reticulum (ER) homeostasis
[15,16]. This leads to the disruption of protein folding, the
accumulation of unfolded proteins and ER stress response or
unfolded protein response (UPR) to restore ER normal function.
One of the major components of UPR is the degradation of
misfolded proteins by the proteasome (ER associated degradation,
ERAD) [15,16]. We therefore determined if the decrease of
cytokine secretion observed in DC activated by tetra-acyl LPS
could be due to a proteasome-mediated degradation of newly
synthesized cytokines (Figure 5). Epoxomycine (Figure 5A) or
Mg132 (Figure 5B) proteasome inhibitors were used in BMDC
treated by the different LPS for 8 h and intracellular the IL-12
expression was analysed. As expected, in the absence of
proteasome inhibitors the level of intracellular IL-12 expression
was lower in tetra-acyl LPS-treated DC than in hexa-acyl LPS-
treated DC. However, in the presence of proteasome inhibitors
DC treated with tetra-acyl LPS levels of intracellular IL-12 were
similar to those expressed by DC treated with hexa-acyl LPS
(Figure 5A and B). We then studied the ubiquitinylation of
proteins following DC activation by different LPS. It has been
shown that upon inflammatory stimulation, DC accumulate newly
synthesized ubiquitinylated proteins in large cytosolic structures.
These DC aggresome-like induced structures (DALIS) are
transient and require continuous protein synthesis [16]. Mouse
DC treated with LPS variants underwent maturation and
displayed MHC II surface localization as well as DALIS formation
(Figure 5C). However, after 4 h of tetra-acyl LPS treatment, the
percentage of DALIS-containing cells was significantly higher as
compared to cell stimulated by hexa-acyl LPS (Figure 5C). At
24 h, the number of DALIS decreased, consistent with the
transient DALIS expression previously demonstrated in the
process of DC maturation (not shown) [16]. These data strongly
suggest that tetra-acyl LPS induce a degradation of IL-12 by the
proteasome machinery in DC. It is therefore tempting to
hypothesize that LPS with acylation defects could induce an ER
stress in DC activating the proteasome machinery. This will lead
to the down-regulation of cytokine intracellular levels and
consequently to a decrease of their secretion.
LPS with Acylation Defects Induce Antigen-specific CD8+
and CD4+ T cell Responses
We next studied the antigen presentation capacity of tetra-acyl
LPS-treated DC and their ability to promote T cell responses
(Figure 6). We used transgenic mice that express either a TCR
specific for the MHC class-I restricted OVA (OT-I Rag-22/2) or
a TCR specific for the MHC class-II restricted OVA (OT-II Rag-
22/2). BMDC incubated in either medium alone or medium
containing ovalbumin (OVA) were activated by different LPS and
co-cultured with OTI (CD8+) and OTII (CD4+) T cells for 3 days
(Figure 6A). Basal level of T cell responses was determined.
Figure 1. LPS with acylation defects induce semi-mature mouse and human dendritic cells. Mouse BMDC were stimulated for 8 h (in
grey) and 24 h (in black) with medium, E. coli LPS (either hexa-acyl, penta-acyl or tetra-acyl) and Y. pestis tetra-acyl LPS. All LPS were used at the
concentration of 100 ng/ml. MHC II and co-stimulatory molecules up-regulation on the cell surface was measured by flow cytometry (A) and cytokine
secretion was determined by ELISA (B). Data represent means 6 standard errors of at least 5 independent experiments, **p,0.01, *p = 0.01 to 0.05.
Human blood mDC were stimulated overnight with medium (in grey), hexa-acyl E. coli LPS (in red), tetra-acyl E. coli LPS (in blue) and Y. pestis tetra-acyl
LPS (in orange). Surface expression of HLA-DR, CD83, CD40 and CD86 was analyzed by flow cytometry (C) and cytokine levels in the culture
supernatants were measured by Luminex (D). Experiments were performed on 4 different donors. The data for one representative are shown.
***p,0.001, **p,0.01, *p = 0.01 to 0.05.
doi:10.1371/journal.pone.0055117.g001
Table 1. Characteristics of LPS.
Bacterial strain (relevant genetic features) a Proportions of lipid A species (molecular mass)
E.coli MLK3 .90% hexaacyl (1823.3 Da); traces of penta and tetraacyl.
E.coli MLK53 (htrB-) rough-LPS; pentaacyl lipid A deficient in C12 oxyacyl of 3-OH-C14 acyl at GlcN
C29 (1615.1 Da)
E.coli MLK 1067 (msbB-) rough-LPS; .90% pentaacyl (1587.0 Da); tetraacyl traces
E.coli MLK986 (msbB-, htrB-) rough-LPS; 29% pentaacyl (1643.0 Da); 54% tetraacyl (1404.8 Da); and 17%
triacyl (1178.6 Da)
Y. pestis KIM rough-LPS, 9% hexaacyl (1797.2 Da); 10% pentaacyl; 40% tetraacyl (1404.8 Da);
7% arabinosamine- tetraacyl (1535.9 Da); 30% triacyl (1178.6 Da)
aAll are rough-type LPSs.
doi:10.1371/journal.pone.0055117.t001
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BMDC incubated with LPS alone or OVA alone could not induce
any T cell response (data not shown). However, BMDC incubated
with OVA and activated by different LPS efficiently induced
antigen-specific CD8+ and CD4+ T cell responses (Figure 6A). DC
activated by tetra-acyl LPS induced a higher OTI and OTII T cell
proliferation than cells treated by hexa-acyl LPS (Figure 6A). DC
stimulated by tetra-acyl and hexa-acyl LPS were able to trigger T
cell activation characterized by a CD25 up-regulation and
a CD62L down-regulation. However hexa-acyl LPS-treated
BMDC led to a higher down-regulation of CD62L by OT II T
cells than those treated with tetra-acyl LPS (Figure 6A). Altogeth-
er, these data show that BMDC induced by LPS with acylation
defects are able to efficiently promote antigen presentation and
induce CD8+ and CD4+ T cell responses.
We then investigated the functional properties of human DC
stimulated with LPS variants (Figure 6B). Human blood myeloid
DC (mDC) activated by the different LPS were able to induce the
proliferation of allogeneic naı¨ve CD4+ and CD8+ T cells, although
to a lower level for E. coli tetra-acyl LPS compared to other LPS
(Figure 6B). Tetra-acyl LPS from Y. pestis, which contains small
amounts of hexa-acyl LPS had a stronger capacity to trigger T cell
responses than LPS purified from E. coli (msbB-, htrB-) double
mutant (devoid of hexa-acyl LPS) (Figure 6B, Table 1). These
results show that tetra-acyl LPS-treated DC are able to promote
CD4+ and CD8+ T cell responses both in mouse and human
models.
We then characterized the effector T cells induced by LPS-
treated mDC (Figure 7). Cells were stimulated with PMA/
Ionomycin and stained for intracellular IFN-c (TH1 response), IL-
13 (TH2 response) and IL-17 (TH17 response). mDC stimulated
either by hexa- or tetra-acyl LPS polarized allogeneic naı¨ve CD4+
T cells into IFN-c-expressing TH1 cells (Figure 7A). CD4
+ T cells
co-cultured with either hexa-acyl LPS-activated mDC or tetra-
acyl-activated mDC did not express IL-13 or IL-17 (Figure 7A).
mDC stimulated by tetra-acyl LPS were also able to induce IFN-c
and Granzyme B synthesis in CD8+ T cells (Figure 7B). However,
we observed lower levels of IFN-c and Granzyme B production
with LPS purified from E. coli MLK (msbB-, htrB-) double mutant
compared to other LPS (Figure 7).
These data indicate that DC activated by either hexa-acyl or
tetra-acyl LPS induce TH1 responses and activate CD8
+ T cells.
Figure 2. Tetra-acyl LPS induce the activation of TLR4-dependent molecular pathways involved in mouse DC maturation. BMDC
were activated with medium (grey), E. coli hexa-acyl LPS (dark blue), E. coli tetra-acyl LPS (purple) or Y. pestis tetra-acyl LPS (light blue) for 15 min,
30 min, 1 h and 2 h. NF-kB translocation was analyzed by confocal microscopy(A). Cells were fixed and stained for CD11c (in blue), MHC-II (in green)
and NF-kB subunit p65/RelA (in red). The percentage of BMDC with translocated NF-kB into the nucleus was quantified (B). BMDC were stimulated for
30 min, 1 h, 4 h and 6 h with medium or different LPS. Cell lysates were subjected to SDS-PAGE and, after transfer to nitrocellulose, the membrane
was probed with the antibodies against phospho-S6 (Ser235/236), S6 and an anti-actin antibody (C). Data represent means 6 standard errors of at
least 4 independent experiments, **p,0.01.
doi:10.1371/journal.pone.0055117.g002
Figure 3. Phospho-flow analysis of human IL-4 DC stimulated by LPS. Human IL-4 DC were activated by different LPS for 2 min, 5 min,
10 min, 30 min, 60 min and 180 min. A phospho-flow analysis using fluorescent cell barcoading was performed in order to assess the
phosphorylation levels of molecules involved in TLR4 signaling. The heatmap visualization of phosphorylation changes is shown. The median
fluorescent intensity (MFI) of stimulated cells is normalized by MFI of medium stimulated cells. Colored bar on the right shows the levels of fold
changes. Experiments were performed on 4 different donors. The data for one representative are shown.
doi:10.1371/journal.pone.0055117.g003
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Figure 4. Kinetics of synthesis of pro-inflammatory cytokines. (A) BMDC were stimulated for 2 h, 4 h, 8 h or 24 h with medium (grey), E. coli
hexa-acyl LPS (dark blue), E. coli tetra-acyl LPS (purple) or Y. pestis tetra-acyl LPS (light blue). Total RNA was purified from cell lysates, reverse
transcribed and the amount determined by real-time quantitative PCR. Primers were used for qPCR amplification of actin (control), p35, p40 and TNF-
a genes. 3 independent experiments were done and one representative is shown, **p,0.01. (B) The secretion levels of IL-12p70, IL-12p40 and TNF-
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In Contrast to Murine BMDC, Tetra-acyl LPS Activate
Human DC to Induce Treg cells
DC with MHC IIhigh, co-stimulationhigh, pro-inflammatory
cytokines low phenotype are referred in the literature as semi-
mature. It has been shown that these cells are able to trigger the
differentiation of regulatory T cells (Treg) [17]. We thus evaluated
whether mouse BMDC activated by tetra-acyl LPS displaying
a semi-mature phenotype were capable of generating Treg cells
characterized by the expression of the transcriptional factor Foxp3
and a high CD25 expression at their cell surface. When
maintained on a Rag-22/2 background, transgenic mice that
express a TCR specific for I-Ab-OVA complexes (OT-II Rag-22/2
mice) contain only conventional (Foxp32) CD4+ T cells in their
periphery, a situation that facilitates the measurement of their
conversion into Treg cells [18]. Such conversion requires I-A
b+ DC
and the presence of the OVA-derived peptide specifically
recognized by OT-II CD4+ T cells (Figure S4). It also depends
on the secretion by the antigen-presenting DC of TGF-b [18].
Accordingly, BMDC stimulated with different LPS variants were
incubated with OT-II Rag-22/2 T cells in the presence of the
OVA or OVA257–264 peptide (0.06 mg/mL), with or without TGF-
b (Figure S4). We could observe that OVA and peptide-pulsed
BMDC were both capable of inducing the activation of OT-II
Rag-22/2 CD4+ T cells as measured by CD25 expression (Figure
S4). However, DC stimulation either by tetra-acyl or hexa-acyl
LPS did not trigger Treg responses in mouse BMDC (Figure S4A).
The addition of exogenous TGF-b to the culture did not confer to
LPS-activated DC the ability to generate Treg cells (Figure S4B).
We then studied the capacity of human mDC activated by tetra-
acyl LPS to induce Treg cells. Human DC activated by LPS
variants were co-cultured with allogeneic naı¨ve CD4+ T cells and
Treg population was analysed by flow cytometry (Figure 8). We
could observe that mDC activated by tetra-acyl LPS induced
a higher Treg population characterized by the expression of Foxp3
and a high CD25 expression at the cell surface (Figure 8). This
activation profile could be due to the fact that human DC
activated by different forms of tetraacyl LPS, including the
synthetic Lipid IVa display an intermediate profile of DC
maturation (as shown here for IL-4 DC in Figure S5) then leading
to Treg proliferation.
Discussion
The innate immune system possesses various mechanisms to
detect and facilitate host responses to microbial components such
as LPS [19]. It has been described that each change in chemical
composition of LPS causes a dramatic decrease of its activity down
to a complete loss of endotoxicity [6]. Different cell types, mainly
human and mouse monocytes/macrophages have been used to
study LPS structural requirements for its immunostimulatory
properties. However, to determine the endotoxic activity of
enterobacterial LPS, previous studies have mainly concentrated
on cytokine production. Consequently, a decrease in IL-8, IL-6
and TNF-a secretion by cells stimulated with LPS harboring
acylation defects has been considered as a lack of immunogenicity
or a defect of pro-inflammatory signaling [9,10,20]. In contrast,
we show here that LPS with acylation defects efficiently induce
a potent activation of TLR4-dependent signaling in mouse and
human DC that leads to a strong cytokine synthesis, which in turn
triggers the activation of the proteasome machinery. The
consequence is the degradation of intracellular pro-inflammatory
cytokines and consequently the decrease of their secretion. This
hypothesis corroborates previous results, which showed a decrease
of cytokine secretion in tetra-acyl LPS-treated macrophages
[8,9,10,20].
The difference in the activation potential of LPS variants in
terms of cytokine secretion could affect the output of the DC
immune response. DC activated by tetra-acyl LPS triggered CD4+
T and CD8+ T cell responses both in mouse and human DC.
However, human DC activated by LPS with acylation defects
displayed a semi-mature phenotype and induced Treg responses.
There could be several mechanisms by which tetra-acyl LPS
interact with human DC to elicit distinct types of TH responses.
Functional differences between the different subsets of human
myeloid DC could be one possible explanation. Two main
populations of circulating DC termed myeloid (mDC) and
plasmacytoid (pDC) were identified in the blood of healthy
donors. Additional distinctions can be made within the mDC
subset with CD1c+CD1412 mDC1, CD1c2CD141+ mDC2 and
CD16+ mDC [21]. It has been shown that mDC1 and mDC2
differ for the expression of surface markers, cytokine production
profile and the differentiation of TH responses. When co-cultured
with purified human peripheral blood cells, mDC1 produce IL-12
and favor TH1 differentiation, while mDC2 produce high levels of
IL-10 and direct the differentiation of TH2. Moreover, the
identification of numerous phenotypic and functional differences
among pulmonary mDC1 and mDC2 suggests a possible prefer-
ential role for mDC2 in regulating immunity and disease
pathogenesis in the respiratory tract distinct from that of mDC1.
Distinct roles in host immunity for each human DC were
previously shown [21,22,23,24]. For instance, the human
CD1c2CD141+ mDC2 subset is the functional equivalent of
mouse CD8a+ DC, capable of cross presentation of exogenous
antigens. Regarding their capacity to secrete IL-10, mDC2 might
also induce Treg populations.
Treg are key players in the immune regulation, particularly in
tolerance. This cell population plays a crucial role in suppressing
immune responses to self-antigens and in preventing autoimmune
diseases [25,26]. Evidence is emerging that Treg can control
immune responses to pathogens. They are beneficial to the host
through limiting the immunopathology associated with anti-
pathogen immune responses and enabling the development of
immune memory. However, pathogens can exploit Treg to subvert
the protective immune responses of the host in order to survive
and establish a chronic infection [27,28]. Microbes have evolved
strategies for programming DC to induce Treg in order to maintain
immune homeostasis that controls unbridled host immunity
[4,27]. For example, filamentous hemagglutinin (FHA) from the
bacteria Bordetella pertusis induces DC to provide IL-10 and prime
Treg. Moreover, Yersinia pestis is known to activate DC by means of
the dimer of TLR2 and TLR6 to induce Treg [29].
There is growing evidence that the induction of tolerance is not
restricted to immature DC. Within the tolerogenic pool of DC,
a third population is proposed, called semi-mature [17]. This new
subset or developmental stage of DC is distinguished as mature by
their surface marker analysis (MHC IIhigh and co-stimulation high).
a were determined by ELISA. Data represent means6 standard errors of at least 4 independent experiments, **p,0.01. (C, D) BMDC were treated for
2 h and 4 h with medium, E. coli LPS (either hexa-acyl or tetra-acyl LPS) and Y. pestis tetra-acyl LPS. The intracellular synthesis of IL-12 (p40+p70) in (C)
and TNF-a in (D) was analysed by flow cytometry. (E) The intracellular IL-12 and TNF-a production was studied in BMDC activated for 8 h with LPS
variants. At least 3 independent experiments were performed and one representative is shown.
doi:10.1371/journal.pone.0055117.g004
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Figure 5. Tetra-acyl LPS induce a degradation of IL-12 by the proteasome machinery in DC. BMDC were activated for 8 h with LPS
variants in the presence or the absence of proteasome inhibitors such as epoxomycine (A) and Mg132 (B). The intracellular IL-12 (p40+p70) synthesis
was then analysed. At least 3 independent experiments were performed and one representative is shown. (C) BMDC were activated for 2 h, 4 h, 8 h
and 24 h with LPS variants and labelled with anti-MHC II(green), anti-CD11c (blue) and FK2 (red) antibodies to detect DALIS (white arrows).
Quantification of the percentage of DC with DALIS at 2 h, 4 h and 8 h post-incubation with medium or post-stimulation with the different LPS.
Quantifications were done by counting at least 300 cells in 3 independent experiments. Data represent means 6 standard errors of at least 3
independent experiments, *p = 0.01 to 0.05.
doi:10.1371/journal.pone.0055117.g005
Figure 6. LPS with acylation defects induce functional mouse and human dendritic cells. BMDC were incubated overnight with OVA and
activated for 8 h with different LPS. Stimulated DC were co-cultured with T cells from OT-I and OT-II Rag-22/2 mice (A). The proliferation of OT-I and
OT-II T cells was assessed after 3 days of co-culture by CFSE decrease. For T cell activation assays, the expression of surface markers such as CD25 and
CD62L was analyzed by flow cytometry. At least 3 independent experiments were performed and one representative is shown. (B) CFSE-labeled
allogeneic naı¨ve CD4+ T and CD8+ T cells were co-cultured with activated mDC for 7 days. Cell division was tested by measuring CFSE-dilution
Experiments were performed on 4 different donors. Data for one representative experiment are shown.
doi:10.1371/journal.pone.0055117.g006
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Figure 7. Tetra-acyl LPS induce effector molecules synthesis by human T cells. Human blood mDC were activated overnight either by
medium or LPS variants and co-cultured with allogeneic naı¨ve CD4+ T and CD8+ T cells. After 7 days, cells were incubated 6 h with PMA/Ionomycine
in the presence of Brefeldin A. The intracellular levels of IFN-c, IL-13 and IL-17 in CD4+ T (A) and IFN-c and Granzyme B in CD8+ T cells (B) were
analysed by flow cytometry. Experiments were performed on 4 different donors. Data for one representative experiment are shown.
doi:10.1371/journal.pone.0055117.g007
Figure 8. LPS with acylation defects activate human mDC to induce regulatory T cells. Human blood mDC were activated overnight either
by medium or different LPS and co-cultured with allogeneic naı¨ve CD4+ T cells. After 7 days, cells were incubated 6 h with PMA/Ionomycine in the
presence of Brefeldin A. Foxp3 and CD25 expression was analysed in CD4+ T cell population. Experiments were performed on 4 different donors. Data
for 2 representatives are shown.
doi:10.1371/journal.pone.0055117.g008
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However, semi-mature DC do not release high level of pro-
inflammatory cytokines, such as IL-1b, IL-6, TNF-a or IL-12p40
or IL-12p70. IL-10 production by semi-mature DC has been
described, but it is not an absolute requirement for Treg
differentiation [17]. Inducers of DC semi-maturation can be
lactobacilli from the gut flora [30], intranasally applied OVA [31],
apoptotic cells [32], Bordetella pertussis FHA [33] or TNF-a [34].
Here we show that, structural modifications of LPS are able to
induce semi-mature human and mouse DC characterized by
MHC-IIhigh, co-stimulationhigh, pro-inflammatory cytokines low
phenotype. In the human model, these semi-mature DC induce
high levels of Treg cells.
In conclusion, we describe a new mechanism, which regulates
the pro-inflammatory cytokine decrease in cells activated by LPS
with acylation defects. We propose that cell stimulation by tetra-
acyl LPS trigger the activation of the proteasome machinery. This
leads to the degradation of intracellular pro-inflammatory cytokine
levels and consequently to a decrease of their secretion. Our results
provide new insights into the understanding of early steps of
endotoxin action and suggest that structural modifications of LPS
could represent an important strategy for pathogens to subvert
adaptive immunity by Treg cell induction in order to survive.
Supporting Information
Figure S1 LPS structure effect on mouse BMDM
activation. Mouse BMDM were incubated with medium, E. coli
hexa-acyl LPS (dark blue), E. coli tetra-acyl LPS (purple) or Y. pestis
tetra-acyl LPS (light blue). Secretion levels of TNF-a were
determined by ELISA after 8 h and 24 h of cell activation. Data
represent means 6 standard errors of at least 4 independent
experiments. **p,0.01.
(EPS)
Figure S2 Tetra-acyl LPS induce a TLR4-dependent DC
activation. BMDC from wild type and Tlr42/2 mice (A) or
Tlr22/2 mice (B) were stimulated for 8 h and 24 h with medium
(grey) or E. coli hexa-acyl LPS (dark blue), E. coli tetra-acyl LPS
(purple) or Y. pestis tetra-acyl LPS (light blue) or Pam2CSK4
(brown). TNF-a secretion was measured by ELISA. Data
represent means 6 standard errors of at least 3 independent
experiments, ***p,0.001, **p,0.01.
(EPS)
Figure S3 LPS effect on mouse NF-kB translocation in
mouse BMDM. Mouse BMDM were incubated with medium
(grey), E. coli hexa-acyl LPS (dark blue), E. coli tetra-acyl LPS
(purple) or Y. pestis tetra-acyl LPS (light blue). (A) NF-kB
translocation was analyzed by confocal microscopy in cells
activated with different LPS for 15 min, 30 min, 1 h and 2 h.
Cells were fixed and stained for NF-kB subunit p65/RelA (in red).
The percentage of BMDM with translocated NF-kB into the
nucleus was quantified (B). Data represent means 6 standard
errors of at least 4 independent experiments, **p,0.01.
(EPS)
Figure S4 BMDC capacity to trigger Treg cell differen-
tiation. BMDC stimulated with different LPS variants were
incubated with OT-II Rag-22/2 T cells in the presence of the
OVA, OVA257–264 peptide (0.06 mg/mL) with or without TGF-b.
After 5 days of culture, T cells were analyzed for the expression of
Foxp3 and of CD25. Numbers in outlined areas indicate
percentage of cells. Results for hexa-acyl and tetra-acyl E. coli
LPS are shown. Data similar to tetra-acyl E. coli LPS are observed
while BMDC are stimulated with tetra-acyl Y. pestis LPS. Data are
representative of 3 independent experiments.
(EPS)
Figure S5 Human IL-4 DC stimulation properties in the
presence of E. coli LPS analogs and Y. pestis LPS. IL-
4 DC were stimulated for 72 h with medium, hexa-acyl E. coli
LPS, tetra-acyl E. coli LPS, synthetic Lipid IVa and Y. pestis at
20 ng/ml. Cell culture supernatants were kept for cytokine
measurement (IL-6, IL-10 and TNFa) by Luminex (A). Surface
expression of HLA-DR, CD80 and CD86 was analyzed by flow
cytometry (B) Experiments were performed on 4 different donors.
Data for one representative donor are shown.
(TIF)
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